Grants, prizes and donations
The Swedish Cancer and Allergy Fund grants SEK 2.3 million to KI researchers
Cancer- och allergifonden (the Swedish Cancer and Allergy Fund) is awarding a total of SEK 3.6 million to 21 research projects in the field of cancer and allergy. Of these, twelve researchers at Karolinska Institutet will be awarded SEK 2.3 million. The grants aim to promote groundbreaking research that improves the diagnosis, treatment and prevention of cancer and allergies.
Mats Paulsson Foundations allocate SEK 10 million to Alzheimer's research at KI
The Mats Paulsson Foundations award Jan Johansson, professor at the Department of Medicine, Huddinge, Karolinska Institutet, SEK 10 million for research into new innovative treatment methods for Alzheimer's disease. The aim of the research project is to create a new drug that can achieve a breakthrough in the treatment of the most common dementia disease.
More than SEK 80 million from the Swedish Childhood Cancer Foundation for KI projects
The Swedish Childhood Cancer Foundation is awarding more than SEK 80 million to Karolinska Institutet for paediatric oncology research in 2024. The allocation includes 29 projects run by researchers at KI.
KI researcher Camilla Björkegren awarded a distinguished professor grant
Professor Camilla Björkegren at the Department of Cell and Molecular Biology, Karolinska Institutet, is awarded a distinguished professor grant within natural and engineering sciences by the Swedish Research Council. Out of 83 applications, four grants are awarded to four different universities.
The Nobel Prize
The Nobel Prize in Physiology or Medicine 2024: “A groundbreaking discovery that has finally been rewarded”
Gary Ruvkun and Victor Ambros share this year's Nobel Prize in Physiology or Medicine. They are being awarded for their discovery of microRNAs, which play a crucial role in the development of complex organisms. Research is underway at Karolinska Institutet on how these small molecules can be applied clinically.
Nobel Prize laureates at KI
Professor Bengt Samuelsson is one of several KI researchers who have been awarded the Nobel Prize for groundbreaking research.
The Nobel Prize in Physiology or Medicine
The Nobel Assembly at Karolinska Institutet appoints the laureates of the Nobel Prize in Physiology or Medicine. The laureate is announced on the first Monday in October every year.
The extraordinary life of Alfred Nobel
Alfred Nobel, the inventor and entrepreneur has left a lasting legacy with the annual prizes he established in 1901 for physics, chemistry, physiology or medicine, literature and peace. But life wasn’t always so illustrious for Alfred Nobel, writes Professor Jonas F. Ludvigsson in The Conversation.
The Conversation
Eight reasons why ADHD diagnoses are increasing
The rate of children diagnosed with ADHD has increased significantly in recent years. In an article in The Conversation, KI Professor Sven Bölte explains why this is the case.
Does psilocybin really provide long-term relief from depression, as new study suggests?
Recent studies suggest that psilocybin, the active compound in magic mushrooms, shows promise as a treatment for depression, with rapid effects. But is the effect long-lasting? Science does not yet have an answer to this question.
Go with the flow for better health
New research seems to confirm that regular flow, losing yourself in time and space during an activity, has positive health effects. For example, lower risk of cardiovascular disease and depression. At the same time, there are factors that complicate this picture. What is clear, however, is that what brings us joy is good for us.
More articles from KI researchers published in The Conversation
From cold-resistant genes to face masks, Karolinska Institutet researchers contribute to the global public discourse on a range of topics through our collaboration with the international news site The Conversation.
Selected top publications
New insights into wound healing difficulties in chronic diseases
Zhuang Liu et al, Cell Stem Cell, December 2024
Researchers propose new model for funding pandemic preparedness
Hampus Holmer et al, The Lancet, December 2024
How SARS-CoV-2 exploits human proteins to replicate
McInerney et al, Nature Communications, December 2024
Researchers have created an atlas of human embryo development
Fredrik Lanner et al, Nature Methods, November 2024
HPV screening most effective to reduce cervical cancer
Joakim Dillner et al, The Lancet Public Health, October 2024
More high-impact publications